News

Novo Nordisk's Cardiometabolic Portfolio, Led by Semaglutide, Looks Underappreciated
Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. Ozempic and Rybelsus helped Novo gain share over Eli Lilly's once-weekly ...
Myth versus fact: What we know about the risks and side effects of the new weight-loss drugs
The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?
FMIBlog4d
Injectable Drug Delivery Market to Exceed USD 113 Billion by 2034, Driven by Chronic Disease Surge and Device Innovation
The global injectable drug delivery market is experiencing a significant transformation, poised to reach a staggering USD 113 ...
Woman's World on MSN5d
Do GLP-1 Patches Work? Get the Skinny on Natural Ozempic Alternatives
From supplements to injectables to belly-fat blasting beverages, there are plenty of products that claim to speed weight loss ...
Jurnal Time6d
Spot Fake Wegovy! Tips to Authenticate Weight Loss Meds!
A Wegovy pen is placed against a bright concept background in this image shared by GoodRx Health; the product photo is ...